The Discounted Cash Flow (DCF) valuation of Alexion Pharmaceuticals Inc (ALXN) is 24.28 USD. With the latest stock price at 182.50 USD, the upside of Alexion Pharmaceuticals Inc based on DCF is -86.7%.
Based on the latest price of 182.50 USD and our DCF valuation, Alexion Pharmaceuticals Inc (ALXN) is a sell. selling Alexion stocks now will result in a potential gain of 86.7%.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 9.6% | 7.8% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 17.93 - 42.18 | 24.28 |
| Upside | -90.2% - -76.9% | -86.7% |